# Precision Pharmacogenetics and Genotype Class Based Prediction of Mavacamten Response in Obstructive Hypertrophic Cardiomyopathy

> **NCT07408427** · — · NOT_YET_RECRUITING · sponsor: **University of Manchester** · enrollment: 140 (estimated)

## Conditions studied

- Hypertrophic Cardiomyopathy (HCM)

## Interventions

- **OTHER:** Observational study, no new intervention offered

## Key facts

- **NCT ID:** NCT07408427
- **Lead sponsor:** University of Manchester
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2029-06
- **Final completion:** 2029-12
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07408427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07408427, "Precision Pharmacogenetics and Genotype Class Based Prediction of Mavacamten Response in Obstructive Hypertrophic Cardiomyopathy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07408427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*